Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / India - Page 2

India

Novavax and Serum Institute announced submission to WHO for Emergency Use Listing of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Nanotechnology | Vaccine | WHO

Novavax and Serum Institute announced submission to WHO for Emergency Use Listing of COVID-19 vaccine

On Sept. 23, 2021, Novavax with its partner, Serum Institute of India announced a regulatory submission to the…

Read More Novavax and Serum Institute announced submission to WHO for Emergency Use Listing of COVID-19 vaccineContinue

Researchers developed COVID-19 severity screening method based on the Agilent Cary 630 FTIR spectrometer
COVID-19 | Life Science History

Researchers developed COVID-19 severity screening method based on the Agilent Cary 630 FTIR spectrometer

On Aug. 18, 2021, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…

Read More Researchers developed COVID-19 severity screening method based on the Agilent Cary 630 FTIR spectrometerContinue

Illumina donated US $1 Million in sequencing capabilities for COVID-19 genomic surveillance in India
COVID-19 | Diagnostics | Genomics

Illumina donated US $1 Million in sequencing capabilities for COVID-19 genomic surveillance in India

On Aug. 3, 2021, Illumina announced it had donated US $1 million in sequencing capabilities to the Molecular…

Read More Illumina donated US $1 Million in sequencing capabilities for COVID-19 genomic surveillance in IndiaContinue

Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants
Biotechnology | COVID-19 | Pharmaceutical | Therapeutics

Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variants

On Jul. 29, 2021, Cocrystal Pharma announced that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed…

Read More Cocrystal’s SARS-CoV-2 3CL protease lead CDI-45205 demonstrated broad-spectrum activity against SARS-CoV-2 Delta and Gamma variantsContinue

Twist Bioscience began shipping synthetic RNA positive controls for Delta (B.1.617.2) SARS-CoV-2 variant
Life Science History

Twist Bioscience began shipping synthetic RNA positive controls for Delta (B.1.617.2) SARS-CoV-2 variant

On Jul. 22, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…

Read More Twist Bioscience began shipping synthetic RNA positive controls for Delta (B.1.617.2) SARS-CoV-2 variantContinue

Adjuvant developed with NIH funding enhanced efficacy of Indiaメs COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Adjuvant developed with NIH funding enhanced efficacy of Indiaメs COVID-19 vaccine

On Jun. 29, 2021, the National Institutes of Health announced that an adjuvant developed with its funding had…

Read More Adjuvant developed with NIH funding enhanced efficacy of Indiaメs COVID-19 vaccineContinue

Moderna provides a clinical update on neutralizing activity of COVID-19 vaccine on emerging variants
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Moderna provides a clinical update on neutralizing activity of COVID-19 vaccine on emerging variants

On Jun. 29, 2021, Moderna announced new results from in vitro neutralization studies of sera from individuals vaccinated…

Read More Moderna provides a clinical update on neutralizing activity of COVID-19 vaccine on emerging variantsContinue

Moderna announces Emergency Use Authorization for its COVID-19 vaccine granted by Government of India
Biotechnology | COVID-19 | Infectious Disease | Vaccine | WHO

Moderna announces Emergency Use Authorization for its COVID-19 vaccine granted by Government of India

On Jun. 29, 2021, Moderna announced that the government of India had issued a registration certificate and a…

Read More Moderna announces Emergency Use Authorization for its COVID-19 vaccine granted by Government of IndiaContinue

Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants
Biotechnology | COVID-19 | Diagnostics | Therapeutics | Vaccine

Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variants

On Jun. 8, 2021, Twist Bioscience announced that it had started shipping its synthetic RNA reference controls for…

Read More Twist Bioscience began shipping of synthetic RNA controls for Kappa (B.1.617.1) SARS-CoV-2 variantsContinue

Novavax and Gavi executed advance purchase agreement for COVID-19 vaccine for COVAX facility
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax and Gavi executed advance purchase agreement for COVID-19 vaccine for COVAX facility

On May 6, 2021, Novavax announced that it had finalized an advance purchase agreement (APA) with Gavi, the…

Read More Novavax and Gavi executed advance purchase agreement for COVID-19 vaccine for COVAX facilityContinue

U.S. sent first flight of medical supplies to India for COVID-19 fight
COVID-19 | Life Science History

U.S. sent first flight of medical supplies to India for COVID-19 fight

On May 5, 2021, the United States sent its first flight loaded with oxygen cylinders and regulators, N95…

Read More U.S. sent first flight of medical supplies to India for COVID-19 fightContinue

HDT Bio, Gennova Biopharma announced volunteers dosed in phase I/II trials of COVID-19 RNA vaccine in India
COVID-19 | Life Science History | Vaccine

HDT Bio, Gennova Biopharma announced volunteers dosed in phase I/II trials of COVID-19 RNA vaccine in India

On May 4, 2021, HDT Bio announced that its development partner in India, Gennova Biopharmaceuticals, had begun dosing…

Read More HDT Bio, Gennova Biopharma announced volunteers dosed in phase I/II trials of COVID-19 RNA vaccine in IndiaContinue

Merck announced licensing agreements with Indian manufacturers to expand access to molnupiravir for treatment of COVID-19
COVID-19 | Life Science History

Merck announced licensing agreements with Indian manufacturers to expand access to molnupiravir for treatment of COVID-19

On Apr. 27, 2021, Merck announced the company had entered into non-exclusive voluntary licensing agreements for molnupiravir with…

Read More Merck announced licensing agreements with Indian manufacturers to expand access to molnupiravir for treatment of COVID-19Continue

Gilead Sciences announced steps to expand availability of Remdesivir in India
COVID-19 | Life Science History

Gilead Sciences announced steps to expand availability of Remdesivir in India

On Apr. 26, 2021, Gilead Sciences announced that in response to the rapid increase in COVID-19 cases in…

Read More Gilead Sciences announced steps to expand availability of Remdesivir in IndiaContinue

The WHO announced continued review of emerging evidence on AstraZeneca COVID-19 vaccines
COVID-19 | Life Science History | Vaccine | WHO

The WHO announced continued review of emerging evidence on AstraZeneca COVID-19 vaccines

On Apr. 22, 2021, the Strategic Advisory Group of Experts (SAGE) on Immunization annouced updated interim guidance on…

Read More The WHO announced continued review of emerging evidence on AstraZeneca COVID-19 vaccinesContinue

WHO COVID-19 subcommittee announced safety signals related to AstraZeneca COVID-19 vaccine
COVID-19 | Pharmaceutical | Vaccine | WHO

WHO COVID-19 subcommittee announced safety signals related to AstraZeneca COVID-19 vaccine

On Mar. 17, 2021, the WHO reported that the AstraZeneca COVID-19 vaccine (including Covishield) continued to have a…

Read More WHO COVID-19 subcommittee announced safety signals related to AstraZeneca COVID-19 vaccineContinue

COVAX published first round of allocations
COVID-19 | Life Science History | Vaccine | WHO

COVAX published first round of allocations

On Mar. 2, 2021, The Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance and the WHO,…

Read More COVAX published first round of allocationsContinue

COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marked beginning of global rollout
COVID-19 | Life Science History | Vaccine | WHO

COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marked beginning of global rollout

On Feb. 24, 2021, Ghana became the first country outside India to receive COVID-19 vaccine doses shipped via…

Read More COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marked beginning of global rolloutContinue

Novavax announced MOU with Gavi for cumulative supply to COVAX facility of 11 billion doses of COVID-19 vaccine
Biotechnology | COVID-19 | Infectious Disease | Vaccine

Novavax announced MOU with Gavi for cumulative supply to COVAX facility of 11 billion doses of COVID-19 vaccine

On Feb. 18, 2021, Novavax and announced a Memorandum of Understanding (MOU) with Gavi, the Vaccine Alliance, to…

Read More Novavax announced MOU with Gavi for cumulative supply to COVAX facility of 11 billion doses of COVID-19 vaccineContinue

WHO listed 2 additional COVID-19 vaccines for emergency use and COVAX roll-out
COVID-19 | Life Science History | Vaccine | WHO

WHO listed 2 additional COVID-19 vaccines for emergency use and COVAX roll-out

On Feb. 15, 2021, the WHO listed two versions of the AstraZeneca/Oxford COVID-19 vaccine for emergency use, giving…

Read More WHO listed 2 additional COVID-19 vaccines for emergency use and COVAX roll-outContinue

Dynavax and Serum Institute announced first participant dosed in trial evaluating Tdap vaccine adjuvanted with CpG 1018
Life Science History | Vaccine

Dynavax and Serum Institute announced first participant dosed in trial evaluating Tdap vaccine adjuvanted with CpG 1018

On Feb. 3, 2021, Dynavax Technologies and Serum Institute of India announced that the first participant has been…

Read More Dynavax and Serum Institute announced first participant dosed in trial evaluating Tdap vaccine adjuvanted with CpG 1018Continue

Mateon announced completion of ARTI-19 and publication of positive interim data
Biotechnology | COVID-19 | Therapeutics

Mateon announced completion of ARTI-19 and publication of positive interim data

On Feb. 2, 2021, Mateon Therapeutics announced that its ARTI-19 trial, evaluating ARTIVeda / PulmoHeal against COVID-19 in…

Read More Mateon announced completion of ARTI-19 and publication of positive interim dataContinue

Mateon launched mobile app, ARTIHealthTM, remote for respiratory health assessment
Biotechnology | COVID-19 | Therapeutics

Mateon launched mobile app, ARTIHealthTM, remote for respiratory health assessment

On Jan. 25, 2021, Mateon Therapeutics announced that it was launching its mobile app, ARTIHealthTM, for respiratory health…

Read More Mateon launched mobile app, ARTIHealthTM, remote for respiratory health assessmentContinue

Mateon announced positive interim results from its ARTI-19 clinical trial evaluating ARTIVeda against COVID-19
Biotechnology | COVID-19 | Therapeutics

Mateon announced positive interim results from its ARTI-19 clinical trial evaluating ARTIVeda against COVID-19

On Jan. 13, 2021, Mateon Therapeutics reported positive interim results from its ARTI-19 clinical trial evaluating ARTIVedaTM against…

Read More Mateon announced positive interim results from its ARTI-19 clinical trial evaluating ARTIVeda against COVID-19Continue

The Serum Institute of India launched India’s first indigenously developed pneumococcal vaccine
Biotechnology | Disease | Therapeutics | Vaccine

The Serum Institute of India launched India’s first indigenously developed pneumococcal vaccine

On Dec. 28, 2020, Serum Institute of India announced the launch of India’s first indigenously developed pneumococcal vaccine…

Read More The Serum Institute of India launched India’s first indigenously developed pneumococcal vaccineContinue

Serum Institute of India and Dynavax announced first participants dosed in phase 1/2 clinical trial for COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Serum Institute of India and Dynavax announced first participants dosed in phase 1/2 clinical trial for COVID-19 vaccine

On Dec. 23, 2020, Serum Institute of India and Dynavax jointly announced that the first participants had been…

Read More Serum Institute of India and Dynavax announced first participants dosed in phase 1/2 clinical trial for COVID-19 vaccineContinue

Codagenix and Serum Institute commenced first-in-human trial of COVI-VAC single dose, intranasal COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Codagenix and Serum Institute commenced first-in-human trial of COVI-VAC single dose, intranasal COVID-19 vaccine

On Dec. 14, 2020, Codagenix and the Serum Institute of India announced that a Phase 1 clinical trial…

Read More Codagenix and Serum Institute commenced first-in-human trial of COVI-VAC single dose, intranasal COVID-19 vaccineContinue

Serum Institute applied for emergency use authorisation for COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Serum Institute applied for emergency use authorisation for COVID-19 vaccine

On Dec. 7, 2020, the Serum Institute of India (SII) announced that it had applied to Drugs Controller…

Read More Serum Institute applied for emergency use authorisation for COVID-19 vaccineContinue

Mateon announced development update for ARTIVEDA/ARTISHIELD against COVID-19
Biotechnology | COVID-19 | Therapeutics | WHO

Mateon announced development update for ARTIVEDA/ARTISHIELD against COVID-19

On Nov. 30, 2020, Mateon Therapeutics announced that the India arm of ARTI-19 global study was on track…

Read More Mateon announced development update for ARTIVEDA/ARTISHIELD against COVID-19Continue

Biological E Limited started phase I/II clinical trial of its COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

Biological E Limited started phase I/II clinical trial of its COVID-19 vaccine candidate

On Nov. 16, 2020, Biological E. Limited (BE), a Hyderabad-based vaccines and pharmaceutical company, Dynavax Technologies, and Baylor…

Read More Biological E Limited started phase I/II clinical trial of its COVID-19 vaccine candidateContinue

Page navigation

Previous PagePrevious 1 2 3 4 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search